Arginase — Nexus for Wound Healing

16 July 2013 by Lowell Goldsmith, posted in JID Jottings

Photograph of Goldilocks with porridge, bear looking on

Image Source/Image Source/Getty Images

 

Arginase has a rich history in cutaneous biology and pathophysiology, as discussed in this blog on August 1, 2102. It is a topic, like a cicada, that raises its head annually. Its role in wound healing was further investigated by Campbell et al (2013). Arginase was deleted in alternatively activated macrophages, and this enzyme, which  increases several-fold during wound healing in the mouse, was abrogated.  Arginase usually peaks five days after an excisional wound;  in the arginase knockout there was increased inflammation and slowed healing. Chemical inhibitors of arginase mimicked the effects seen in the knockout mouse.  Arginase modulation might be therapeutically useful in wounds with abnormal healing (e.g., keloids or hypertrophic scars) and in wounds with decreased healing, as occurs commonly in diabetes, aging, vascular diseases.  Like other physiological pathways — following the Goldilocks principle may be important, you need just the right amount: not too much and not too little.

 

REFERENCE

Campbell L, Saville CR, Murray PJ, et al (2013) Local Arginase 1 Activity Is Required for Cutaneous Wound Healing. J Invest Dermatol doi:10.1038/jid.2013.164

 

Leave a Reply


5 − three =